Augmenting Computerized Cognitive Training With Vortioxetine for Age-Related Cognitive Decline: A Randomized Controlled Trial.

OBJECTIVE Age-related cognitive decline, the deterioration in functions such as memory and executive function, is faced by most older adults and affects function and quality of life. No approved treatments exist for age-related cognitive decline. Computerized cognitive training has been shown to provide consistent albeit modest improvements in cognitive function as measured by neuropsychological testing. Vortioxetine, an antidepressant medication, has putative procognitive and proneuroplastic properties and therefore may be able to augment cognitive training. In this placebo-controlled study, the authors tested the cognitive benefits of vortioxetine added to cognitive training for adults age 65 or older with age-related cognitive decline. METHODS After a 2-week lead-in period of cognitive training, 100 participants were randomly assigned to receive either vortioxetine or placebo in addition to cognitive training for 26 weeks. The primary outcome measure was global cognitive performance, assessed by the NIH Toolbox Cognition Battery Fluid Cognition Composite. The secondary outcome measure was functional cognition, assessed by the UCSD Performance-Based Skills Assessment. All participants received motivational messaging and support from study staff to maximize adherence to the training. RESULTS Participants who received vortioxetine with cognitive training showed a greater increase in global cognitive performance compared with those who received placebo with cognitive training. This separation was significant at week 12 but not at other assessment time points. Both groups showed improvement in the secondary outcome measure of functional cognition, with no significant difference between groups. CONCLUSIONS Vortioxetine may be beneficial for age-related cognitive decline when combined with cognitive training. These findings provide new treatment directions for combating cognitive decline in older adults.

[1]  K. Nuechterlein,et al.  Evaluation of a plasticity-based cognitive training program in schizophrenia: Results from the eCaesar trial , 2019, Schizophrenia Research.

[2]  A. Nierenberg,et al.  Treatment effects on residual cognitive symptoms among partially or fully remitted patients with major depressive disorder: A randomized, double-blinded, exploratory study with vortioxetine. , 2019, Journal of affective disorders.

[3]  A. Troyer,et al.  The impact of memory-strategy training interventions on participant-reported outcomes in healthy older adults: A systematic review and meta-analysis. , 2019, Psychology and aging.

[4]  A. Rutjes,et al.  Computerised cognitive training for maintaining cognitive function in cognitively healthy people in late life. , 2019, The Cochrane database of systematic reviews.

[5]  Philip D. Harvey,et al.  Guanfacine Augmentation of a Combined Intervention of Computerized Cognitive Remediation Therapy and Social Skills Training for Schizotypal Personality Disorder. , 2019, The American journal of psychiatry.

[6]  E. D. Kirby,et al.  Aging gracefully: social engagement joins exercise and enrichment as a key lifestyle factor in resistance to age-related cognitive decline , 2019, Neural regeneration research.

[7]  Luis E. B. Bettio,et al.  The effects of aging in the hippocampus and cognitive decline , 2017, Neuroscience & Biobehavioral Reviews.

[8]  G. Dawson,et al.  Vortioxetine reduces BOLD signal during performance of the N-back working memory task: a randomised neuroimaging trial in remitted depressed patients and healthy controls , 2017, Molecular Psychiatry.

[9]  C. Bowie,et al.  Action-Based Cognitive Remediation for Individuals With Serious Mental Illnesses: Effects of Real-World Simulations and Goal Setting on Functional and Vocational Outcomes , 2017, Psychiatric rehabilitation journal.

[10]  R. Lam,et al.  Efficacy of Vortioxetine on Cognitive Functioning in Working Patients With Major Depressive Disorder. , 2017, The Journal of clinical psychiatry.

[11]  C. Ritchie,et al.  Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research , 2015, Alzheimer's Research & Therapy.

[12]  J. Zajecka,et al.  A Randomized, Placebo-Controlled, Active-Reference, Double-Blind, Flexible-Dose Study of the Efficacy of Vortioxetine on Cognitive Function in Major Depressive Disorder , 2015, Neuropsychopharmacology.

[13]  Michael B. First,et al.  Structured Clinical Interview for the DSM (SCID) , 2015 .

[14]  A. Lampit,et al.  Computerized Cognitive Training in Cognitively Healthy Older Adults: A Systematic Review and Meta-Analysis of Effect Modifiers , 2014, PLoS medicine.

[15]  R. Sperling,et al.  The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. , 2014, JAMA neurology.

[16]  Robert K. Heaton,et al.  Reliability and Validity of Composite Scores from the NIH Toolbox Cognition Battery in Adults , 2014, Journal of the International Neuropsychological Society.

[17]  C. Bowie,et al.  Cognitive Remediation for Treatment-Resistant Depression: Effects on Cognition and Functioning and the Role of Online Homework , 2013, The Journal of nervous and mental disease.

[18]  Denise C. Park,et al.  The aging mind: neuroplasticity in response to cognitive training , 2013, Dialogues in clinical neuroscience.

[19]  Philip D. Harvey,et al.  Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. , 2012, The American journal of psychiatry.

[20]  S. Vinogradov,et al.  Neuroplasticity-based cognitive training in schizophrenia: an interim report on the effects 6 months later. , 2010, Schizophrenia bulletin.

[21]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[22]  B. Christensen,et al.  Measuring premorbid IQ in traumatic brain injury: An examination of the validity of the Wechsler Test of Adult Reading (WTAR) , 2008, Journal of clinical and experimental neuropsychology.

[23]  Judy Illes,et al.  Neurocognitive enhancement: what can we do and what should we do? , 2004, Nature Reviews Neuroscience.

[24]  George W Rebok,et al.  Effects of cognitive training interventions with older adults: a randomized controlled trial. , 2002, JAMA.

[25]  L. Cahill,et al.  Ginkgo biloba: A Cognitive Enhancer? , 2002, Psychological science in the public interest : a journal of the American Psychological Society.

[26]  T. Salthouse,et al.  Decomposing adult age differences in working memory. , 1991 .

[27]  F. Artigas,et al.  Vortioxetine, a novel antidepressant with multimodal activity: review of preclinical and clinical data. , 2015, Pharmacology and Therapeutics.

[28]  M. Trivedi,et al.  REVAMP - Research Evaluating the Value of Augmenting Medication with Psychotherapy: rationale and design. , 2008, Psychopharmacology bulletin.

[29]  D. Hopko,et al.  Assessing worry in older and younger adults: Psychometric properties of an abbreviated Penn State Worry Questionnaire (PSWQ-A). , 2006, Journal of anxiety disorders.

[30]  R. Spitzer,et al.  The PHQ-9: validity of a brief depression severity measure. , 2001, Journal of general internal medicine.